CEO, OncoCyte
Biography
Ron is a 35+ year veteran of the Diagnostics and Molecular Diagnostics markets and is currently the CEO of Oncocyte. He was an early pioneer in the development and commercialization of molecular panels in Oncology. He is an ardent ambassador for decentralization of molecular testing to ensure access to this life saving information to all patients in all communities.
Clinical Dx showcase:
Oncocyte
Oncocyte is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
Driving a Paradigm Shift for Patient Management
As cancer continues to move from a deadly disorder to a manageable chronic disease, a new paradigm for molecular diagnostics is emerging to better serve patient and physicians. Combining precision therapy selection tests with blood based monitoring enables better outcomes.
Session Abstract – PMWC 2022 Silicon Valley
Track 6 - June 28 9.00 A.M.-4.45 P.M.,Track 6 - June 29 3.30 P.M.-3.45 P.M.,Track 6 - June 30 9.00 A.M.-1.15 P.M.
The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative
